Evolent Health (EVH) Stock Forecast, Price & News

Evolent Health (NYSE:EVH) Frequently Asked Questions

Is Evolent Health a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Evolent Health stock.
View analyst ratings for Evolent Health or view top-rated stocks.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Evolent Health.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings results on Wednesday, May, 4th. The technology company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.20. The technology company had revenue of $297.10 million for the quarter, compared to analysts' expectations of $286.81 million. Evolent Health had a negative trailing twelve-month return on equity of 0.86% and a negative net margin of 3.35%. Evolent Health's revenue was up 37.7% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.06) earnings per share.
View Evolent Health's earnings history.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its second quarter 2022 earnings guidance on Monday, May, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $290.00 million-$305.00 million, compared to the consensus revenue estimate of $285.39 million.

What price target have analysts set for EVH?

3 Wall Street analysts have issued 1-year price objectives for Evolent Health's stock. Their forecasts range from $35.00 to $45.00. On average, they expect Evolent Health's stock price to reach $40.00 in the next twelve months. This suggests a possible upside of 36.1% from the stock's current price.
View analysts' price targets for Evolent Health or view top-rated stocks among Wall Street analysts.

Who are Evolent Health's key executives?

Evolent Health's management team includes the following people:

• Mr. Frank John Williams, Co-Founder & Non-Exec. Chairman (Age 55, Pay $1.11M) (LinkedIn Profile)
• Mr. Seth Barrie Blackley, Co-Founder, CEO & Director (Age 43, Pay $1.15M)
• Mr. John Paul Johnson, Chief Financial Officer (Age 38, Pay $761.4k)
• Mr. Steve Tutewohl, Chief Operating Officer (Age 49, Pay $1.09M) (LinkedIn Profile)
• Mr. Aammaad Shams, Principal Accounting Officer & Corp. Controller (Age 38, Pay $316.23k)
• Mr. Jonathan David Weinberg, Chief Legal Officer, Gen. Counsel & Sec. (Age 54, Pay $513.07k)
• Mr. Seth R. Frank, VP of Investor Relations
• Ms. Jessica Somers, Sr. VP of Corp. Devel.
• Dr. Norman C. Payson, Advisor (Age 73)
• Dr. John Tam M.D., Chief Strategy Officer

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health CEO Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among Evolent Health's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Evolent Health's key competitors?

Some companies that are related to Evolent Health include R1 RCM (RCM), Terminix Global (TMX), Premier (PINC), ManTech International (MANT), Franklin Covey (FC), PHI Group (PHIL), Jupai (JP), Rainmaker Systems (VCTL) and Taylor Consulting (TAYO).
View all of EVH's competitors.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering (IPO) on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.43%), Engaged Capital LLC (7.80%), BlackRock Inc. (6.81%), Granahan Investment Management LLC (4.98%), Dimensional Fund Advisors LP (3.52%) and Bellevue Group AG (2.88%). Company insiders that own Evolent Health stock include Cheryl Scott, Frank J Williams, Frank J Williams, Jonathan Weinberg, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends for Evolent Health.

Which institutional investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Engaged Capital LLC, Granahan Investment Management LLC, 13D Management LLC, Sectoral Asset Management Inc., Dimensional Fund Advisors LP, First Trust Advisors LP, and Peregrine Capital Management LLC. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Seth Blackley, Simon Maisey, and Steve Tutewohl.
View insider buying and selling activity for Evolent Health or view top insider-selling stocks.

Which institutional investors are buying Evolent Health stock?

EVH stock was acquired by a variety of institutional investors in the last quarter, including Invesco Ltd., Loomis Sayles & Co. L P, Fuller & Thaler Asset Management Inc., Rock Springs Capital Management LP, BlackRock Inc., Principal Financial Group Inc., Vanguard Group Inc., and Truist Financial Corp.
View insider buying and selling activity for Evolent Health or or view top insider-buying stocks.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $29.39.

How much money does Evolent Health make?

Evolent Health has a market capitalization of $2.69 billion and generates $907.96 million in revenue each year. The technology company earns $-37.60 million in net income (profit) each year or ($0.38) on an earnings per share basis.

How many employees does Evolent Health have?

Evolent Health employs 3,500 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at (571) 389-6000, via email at [email protected], or via fax at 571-389-6001.